Cargando…
Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis
BACKGROUND: Results of studies on the efficacy of atorvastatin pretreatment on reducing the prevalence of contrast-induced acute kidney injury (CIAKI) in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI) have been controversial. OBJECTIVE: We undertook a meta...
Autores principales: | Liu, Ling-Yun, Liu, Yang, Wu, Mei-Yan, Sun, Yan-Yan, Ma, Fu-Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840281/ https://www.ncbi.nlm.nih.gov/pubmed/29535505 http://dx.doi.org/10.2147/DDDT.S149106 |
Ejemplares similares
-
The preventive effects of different doses of atorvastatin on contrast‐induced acute kidney injury after CT perfusion
por: Yan, Shi‐Xin, et al.
Publicado: (2022) -
Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2014) -
Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography
por: Bei, Wei-Jie, et al.
Publicado: (2017) -
Atorvastatin protects against contrast-induced acute kidney injury via upregulation of endogenous hydrogen sulfide
por: Yan, Lin, et al.
Publicado: (2020) -
Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury
por: Zhang, Jing, et al.
Publicado: (2018)